rivastigmine has been researched along with Apoplexy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, R; Bazan, SG; Braga, GP; El Dib, R; Luvizutto, GJ; Resende, LA | 1 |
| de Kort, PL; Jansen, BP; Kappelle, LJ; Oldenbeuving, AW; Roks, G | 1 |
| Chang, HM; Chen, CP; Chen, I; Corrales, MP; Effendy, S; Hia, SB; Lee, JM; Narasimhalu, K; Sim, CH; Tan, EK; Wong, MC; Xue, HL | 1 |
| Fedorov, BB; Khlystov, IuV; Litvineneko, IV; Odinak, MM; Perstnev, SV | 1 |
| Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G | 1 |
| Farlow, MR | 1 |
2 review(s) available for rivastigmine and Apoplexy
| Article | Year |
|---|---|
Pharmacological interventions for unilateral spatial neglect after stroke.
Topics: Administration, Cutaneous; Humans; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Perceptual Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Stroke; Stroke Rehabilitation | 2015 |
Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Topics: Cholinesterase Inhibitors; Dementia, Vascular; Diagnosis, Differential; Donepezil; Dopamine Agents; Galantamine; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Stroke | 2006 |
3 trial(s) available for rivastigmine and Apoplexy
| Article | Year |
|---|---|
A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
Topics: Administration, Oral; Aged; Aged, 80 and over; Brain Ischemia; Cholinesterase Inhibitors; Delirium; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Pilot Projects; Psychiatric Status Rating Scales; Rivastigmine; Stroke; Treatment Outcome | 2008 |
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Executive Function; Female; Humans; Male; Middle Aged; Phenylcarbamates; Pilot Projects; Rivastigmine; Stroke; Treatment Outcome | 2010 |
[Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Confusion; Female; Humans; Male; Phenylcarbamates; Rivastigmine; Stroke; Syndrome; Treatment Outcome | 2010 |
1 other study(ies) available for rivastigmine and Apoplexy
| Article | Year |
|---|---|
Emerging therapies for vascular dementia and vascular cognitive impairment.
Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic | 2004 |